Small Molecule Protein Degradation Agent Market: A New Frontier in Drug Discovery
The small molecule protein degradation agent market is experiencing remarkable growth, driven by the rising demand for innovative therapeutic solutions, particularly in oncology and neurodegenerative diseases. Small molecule protein degradation agents—including proteolysis targeting chimeras (PROTACs), molecular glues, and live cell E3 ligase modulators—represent a paradigm shift in...
0 Commentarios 0 Acciones 78 Views 0 Vista previa